Sommario

• • ·Conference committees

    Pagina :A1

    Mappa Mappa
• • ·Preface

    Pagina :S153

    Michael B. Kimmey, Martin L. Freeman

    
• • ·A day in court for ERCP: A plea answered

    Pagina :S154

    Frank A. Hamilton

    Mappa Mappa
• • ·Overview of the role of ERCP in the management of diseases of the biliary tract and the pancreas

    Pagina :S157

    David L. Carr-Locke

    Mappa Mappa  
• • ·Evidence-based review of ERCP: introduction and description of systematic review methods

    Pagina :S161

    Carole R. Flamm, David H. Mark, Naomi Aronson

    Mappa Mappa
• • ·Epidemiology and natural history of common bile duct stones and prediction of disease

    Pagina :S165

    Cynthia W. Ko, Sum P. Lee

    Mappa Mappa
• • ·Therapeutic role of ERCP in the management of suspected common bile duct stones

    Pagina :S170

    David L. Carr-Locke

    Mappa Mappa  
• • ·EUS for bile duct stones: How does it compare with ERCP?

    Pagina :S175

    Michael V. Sivak

    
• • ·MRCP and ERCP in the diagnosis of common bile duct stones

    Pagina :S178

    Ann S. Fulcher

    Mappa Mappa  
• • ·Surgical management of common bile duct stones

    Pagina :S183

    Joseph B. Petelin

    Mappa Mappa  
• • ·Evidence-based assessment of diagnostic modalities for common bile duct stones

    Pagina :S190

    David H. Mark, Carole R. Flamm, Naomi Aronson

    Mappa Mappa
• • ·The epidemiology of pancreatic, gallbladder, and other biliary tract cancers

    Pagina :S195

    Dominique S. Michaud

    Mappa Mappa
• • ·Diagnostic and therapeutic uses of ERCP in pancreatic and biliary tract malignancies

    Pagina :S201

    Robert H. Hawes

    Mappa Mappa
• • ·CT and magnetic resonance imaging in pancreatic and biliary tract malignancies

    Pagina :S206

    Koenraad J. Mortele, Hoon Ji, Pablo R. Ros

    Mappa Mappa  
• • ·ERCP and surgical intervention in pancreatic and biliary malignancies

    Pagina :S213

    Steven M. Strasberg

    Mappa Mappa
• • ·Evidence-based assessment of ERCP approaches to managing pancreaticobiliary malignancies

    Pagina :S218

    Carole R. Flamm, David H. Mark, Naomi Aronson

    Mappa Mappa
• • ·Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis

    Pagina :S226

    Peter A. Banks

    Mappa Mappa  
• • ·Role of ERCP in acute pancreatitis

    Pagina :S231

    Richard Kozarek

    Mappa Mappa  
• • ·Role of ERCP and other endoscopic modalities in chronic pancreatitis

    Pagina :S237

    Glen A. Lehman

    Mappa Mappa
• • ·The role of US and CT in pancreatitis

    Pagina :S241

    Mary Ann Turner

    Mappa Mappa  
• • ·Surgery for acute and chronic pancreatitis

    Pagina :S246

    Howard A. Reber

    Mappa Mappa
• • ·Evidence-based assessment of ERCP in the treatment of pancreatitis

    Pagina :S249

    David H. Mark, F. Lefevre, Carole R. Flamm, Naomi Aronson

    Mappa Mappa
• • ·Overview of differential diagnoses of abdominal pain

    Pagina :S255

    Anthony N. Kalloo

    Mappa Mappa
• • ·What is the role of ERCP in the setting of abdominal pain of pancreatic or biliary origin (suspected sphincter of Oddi dysfunction)?

    Pagina :S258

    Stuart Sherman

    Mappa Mappa
• • ·There is no role for ERCP in unexplained abdominal pain of pancreatic or biliary origin

    Pagina :S267

    Pankaj Jay Pasricha

    Mappa Mappa
• • ·Adverse outcomes of ERCP

    Pagina :S273

    Martin L. Freeman

    Mappa Mappa
• • ·Income and outcome metrics for the objective evaluation of ERCP and alternative methods

    Pagina :S283

    Peter B. Cotton

    Mappa Mappa  
• • ·What are the determinants of success in utilization of ERCP in the setting of pancreatic and biliary diseases?

    Pagina :S291

    Glen A. Lehman

    Mappa Mappa
• • ·Evidence-based assessment: Patient, procedure, or operator factors associated with ERCP complications

    Pagina :S294

    Naomi Aronson, Carole R. Flamm, Rhonda L. Bohn, David H. Mark, Theodore Speroff

    Mappa Mappa